Green Alpha Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,397
Closed -$461K 154
2022
Q1
$461K Buy
6,397
+642
+11% +$46.3K 0.31% 108
2021
Q4
$528K Buy
5,755
+296
+5% +$35.4K 0.36% 107
2021
Q3
$692K Buy
5,459
+307
+6% +$44.7K 0.48% 103
2021
Q2
$857K Sell
5,152
-16
-0.3% -$2.59K 0.58% 84
2021
Q1
$939K Buy
5,168
+1,018
+25% +$236K 0.93% 44
2020
Q4
$830K Buy
+4,150
New +$844K 1% 37

Other funds holding TDOC

Green Alpha Advisors's TDOC Position: Q2 2022 in Review

Green Alpha Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 6,397 shares — an estimated $461K sold.

Green Alpha Advisors first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $939K in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Green Alpha Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Green Alpha Advisors sold 6,397 Teladoc Health shares in Q2 2022, an estimated $461K.
  • Green Alpha Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
  • Green Alpha Advisors's Teladoc Health position peaked at $939K in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Green Alpha Advisors's 13F filing for Q2 2022, filed 8 Jul 2022.